Immature platelet fraction values predict platelet recovery following consolidation chemotherapy in AML patient
Not Applicable
Recruiting
- Conditions
- The patients older than 18 years with acute myeloid leukemia after receiving chemotherapy.Acute myeloid leukemia,Immature platelet fraction values
- Registration Number
- TCTR20201106003
- Lead Sponsor
- Siriraj Hospital Mahidol University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
The patients older than 18 years with acute myeloid leukemia after receiving periodic chemotherapy consolidation with HiDAC or IDAC formulations
Exclusion Criteria
The patients with disseminated intravascular coagulation (DIC), thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), immune thrombocytopenia (ITP), or systemic lupus erythematosus (SLE) with exacerbation.
Patients with hypersplenism.
Diagnosed with abnormal bone marrow platelet production, including aplastic anemia (AA), myelodysplastic syndrome (MDS).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Embryo platelet proportion the measurement 2 years Number platelet in AML patients per normal population
- Secondary Outcome Measures
Name Time Method The recovery of platelet in AML 2 years Number platelet patients per normal ,The recovery of platelet in AML 2 years Number platelet patients per normal